Tech Company Financing Transactions
ParaGen Technologies Funding Round
Ikove participated in a $3 million capital raise for ParaGen Technologies. The funding round was announced on 11/30/2018.
Transaction Overview
Company Name
Announced On
11/30/2018
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Ikove (Flavio Lobato)
Proceeds Purpose
The funding will be used to commercialize RenovoDerm's proprietary product The Phoenix Wound Matrix, pre-testing for FDA clearance of Tarian Medical's Tarian AbS, as well as beginning the final round of animal testing for Vascular Genesis' vascular access graft product.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1330 Kinnear Rd.
Columbus, OH 43212
USA
Columbus, OH 43212
USA
Phone
Website
Email Address
Not Recorded
Overview
ParaGen Technologies aims to redefine tissue engineering by addressing the problems associated with synthetic and biologic implants; while incorporating their advantages. The company is utilizing synthetic nanofiber scaffolds that promote healing by mimicking the physical structures found naturally in the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ross Kayuha
Chief Operating Officer
Ronald Bracken
Chief Technical Officer
Jed Johnson
Browse more venture capital transactions:
Prev: 11/30/2018: Merchbar venture capital transaction
Next: 11/30/2018: PebblePost venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs